0001601485-21-000011.txt : 20210415
0001601485-21-000011.hdr.sgml : 20210415
20210415160551
ACCESSION NUMBER: 0001601485-21-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210415
FILED AS OF DATE: 20210415
DATE AS OF CHANGE: 20210415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rhodes Jennifer J
CENTRAL INDEX KEY: 0001568249
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 21828545
MAIL ADDRESS:
STREET 1: C/O ADAMAS PHARMACEUTICALS INC.
STREET 2: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Angion Biomedica Corp.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 CHARLES LINDBERGH BOULEVARD
CITY: UNIONDALE
STATE: NY
ZIP: 11553
BUSINESS PHONE: (415) 655-4899
MAIL ADDRESS:
STREET 1: 51 CHARLES LINDBERGH BOULEVARD
CITY: UNIONDALE
STATE: NY
ZIP: 11553
4
1
wf-form4_161851712866164.xml
FORM 4
X0306
4
2021-04-15
0
0001601485
Angion Biomedica Corp.
ANGN
0001568249
Rhodes Jennifer J
C/O ANGION BIOMEDICA CORP.
51 CHARLES LINDBERGH BLVD.
UNIONDALE
NY
11553
0
1
0
0
See Remarks
Common Stock
2021-04-15
4
S
0
399
15.01
D
33887
D
The shares reported in this Form 4 were effected pursuant to a 10b-5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units ("RSUs") of the Issuer.
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
/s/ Jennifer J. Rhodes
2021-04-15